← Back to All Filings

KORU Medical ($KRMD) Appoints New Chief Technology Officer

Low SignificanceJanuary 15, 2026 at 4:02:25 PM EST

KORU Medical Systems, Inc.

$KRMD3CIK: 0000704440

Subscribe to track KRMD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

New CTO at KORU Medical ($KRMD) Files Initial Ownership Statement

Company: KORU Medical Systems, Inc. (KRMD) Form: 3 | Filed: 2026-01-15 Significance: Low

Insider: Schiller Eric Title: Chief Technology Officer | Relationship: Officer

Transaction: • Type: Initial Ownership Statement • Shares: N/A • Price: N/A • Value: N/A • Owned After: 0

Key Insight: This Form 3 filing marks the appointment of Eric Schiller as the new Chief Technology Officer. He currently holds no shares in the company.

Market Context: This is a standard procedural filing required for new insiders and does not represent an insider purchase or sale. It establishes a baseline for future transaction monitoring.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: KORU Medical Systems, Inc. (KRMD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Eric Schiller, the newly appointed Chief Technology Officer, has filed a Form 3 indicating he does not currently own any company stock.
  • Market Impact: Neutral. This is a standard administrative filing required for new corporate insiders.

Company Information

FieldValue
CompanyKORU Medical Systems, Inc.
Ticker SymbolKRMD
CIK0000704440
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameSchiller Eric
CIK0002105459
Title/PositionChief Technology Officer
RelationshipOfficer

Transaction Details

This is a Form 3, an initial statement of beneficial ownership. No market transaction occurred.

FieldValue
Form Type3
Event Date2025-12-29
Transaction CodeN/A
Security TypeCommon Stock
Shares Involved0
Price Per ShareN/A
Total ValueN/A
Shares Owned After0
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

As this is an initial statement of ownership with no transaction, a materiality analysis is not applicable. The filing establishes that the insider's starting ownership is zero shares.

Impact Evaluation

  • Market Cap Context: The company has a market capitalization of approximately $0.20 billion. This filing has no financial impact.
  • Ownership Concentration: The new CTO's ownership is 0%. This filing provides a baseline from which any future purchases will be measured.
  • Dilution Impact: Not applicable.
  • Transaction Significance: The significance is low as no shares were transacted. The event is the appointment of a new officer, which is a routine corporate disclosure.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A Form 3 is a procedural filing for a new insider and does not indicate a buy, sell, or any other market-moving decision.

Volume & Sentiment

  • Expected Volume Impact: None. This type of filing does not typically influence trading volume.
  • Sentiment Indicator: Neutral. The filing is informational and does not carry a bullish or bearish signal.

Additional Context

Transaction Notes

  • Filing Purpose: This Form 3 serves as the initial declaration of securities ownership required under Section 16(a) of the Securities Exchange Act of 1934 for a new officer. It confirms that Eric Schiller held no securities of KORU Medical Systems, Inc. as of the date he became an officer.
Topics:#SECFiling#Form3#KRMD#KRMDStock#InsiderTrading#ExecutiveAppointment#CTO#Investing#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.